Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PuraPharm Corp. Ltd. ( (HK:1498) ) has issued an update.
PuraPharm Corporation Limited has announced the appointment of Dr. Hung Ting On, John as an independent non-executive director, chairman of the audit committee, and member of both the remuneration and nomination committees, effective August 29, 2025. Dr. Hung brings over 40 years of experience in audit, accounting, and finance, having held senior positions at Deloitte Asia Pacific. His extensive expertise in financial audits, IPO projects, and risk management is expected to strengthen the company’s governance and compliance with the Hong Kong Stock Exchange listing rules.
The most recent analyst rating on (HK:1498) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on PuraPharm Corp. Ltd. stock, see the HK:1498 Stock Forecast page.
More about PuraPharm Corp. Ltd.
Average Trading Volume: 221,525
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.7M
For detailed information about 1498 stock, go to TipRanks’ Stock Analysis page.